Bo Ursing

1.4k total citations
38 papers, 1.0k citations indexed

About

Bo Ursing is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, Bo Ursing has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 9 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Bo Ursing's work include Inflammatory Bowel Disease (6 papers), Pancreatitis Pathology and Treatment (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Bo Ursing is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Pancreatitis Pathology and Treatment (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Bo Ursing collaborates with scholars based in Sweden and Denmark. Bo Ursing's co-authors include C. Kamme, F Bárány, I. Nilsson-Ehle, J. Hoevels, Richard Stensman, Örjan Nordle, Per‐Anders Mårdh, Anders Rosén, Bernhard Huitfeldt and Aud Krook and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Bo Ursing

38 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Ursing Sweden 16 447 433 291 210 117 38 1.0k
Kazuo Shiraki Japan 20 492 1.1× 164 0.4× 410 1.4× 242 1.2× 117 1.0× 60 1.5k
J. H. Wandall Denmark 15 239 0.5× 210 0.5× 189 0.6× 91 0.4× 102 0.9× 32 782
C. Kamme Sweden 16 219 0.5× 101 0.2× 121 0.4× 124 0.6× 105 0.9× 30 653
Jae Young Yoo South Korea 20 398 0.9× 193 0.4× 307 1.1× 84 0.4× 157 1.3× 73 1.0k
Hitoshi Tajiri Japan 21 558 1.2× 181 0.4× 401 1.4× 177 0.8× 110 0.9× 107 1.4k
A. Holzel United Kingdom 19 212 0.5× 310 0.7× 178 0.6× 147 0.7× 179 1.5× 53 1.4k
G. Mastella Italy 31 348 0.8× 193 0.4× 402 1.4× 533 2.5× 182 1.6× 87 2.9k
Peter A. Krasilnikoff Denmark 23 547 1.2× 421 1.0× 442 1.5× 355 1.7× 223 1.9× 82 1.7k
Carolyn R. Denning United States 20 352 0.8× 82 0.2× 227 0.8× 73 0.3× 216 1.8× 49 1.5k
Richard J. Summers Australia 8 259 0.6× 314 0.7× 260 0.9× 89 0.4× 158 1.4× 13 864

Countries citing papers authored by Bo Ursing

Since Specialization
Citations

This map shows the geographic impact of Bo Ursing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ursing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ursing more than expected).

Fields of papers citing papers by Bo Ursing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ursing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ursing. The network helps show where Bo Ursing may publish in the future.

Co-authorship network of co-authors of Bo Ursing

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ursing. A scholar is included among the top collaborators of Bo Ursing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ursing. Bo Ursing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitelman, Felix, Bodil Strömbeck, Bo Ursing, Örjan Nordle, & Beryl Hartley‐Asp. (2008). Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients. Hereditas. 96(2). 279–286. 4 indexed citations
2.
Smith, Gudmund J. W., et al.. (1995). Psychological profile of patients suffering from Crohn's disease and ulcerative colitis. Acta Psychiatrica Scandinavica. 92(3). 187–192. 5 indexed citations
3.
Johansson, Peter, et al.. (1992). Septicemia in Granulocytopenic Patients: A Shift in Bacterial Etiology. Scandinavian Journal of Infectious Diseases. 24(3). 357–360. 25 indexed citations
4.
Ståhlberg, Dagny, F Bárány, Kurt Einarsson, et al.. (1991). Neurophysiologic Studies of Patients with Crohn's Disease on Long-Term Treatment with Metronidazole. Scandinavian Journal of Gastroenterology. 26(2). 219–224. 40 indexed citations
5.
Nilsson-Ehle, I., Carl Erik Nord, & Bo Ursing. (1985). Ceftriaxone: Pharmacokinetics and Effect on the Intestinal Microflora in Patients with Acute Bacterial Infections. Archives Internationales de Physiologie. 17(1). 77–82. 1 indexed citations
6.
Ljungberg, Bengt, I. Nilsson-Ehle, & Bo Ursing. (1984). Metronidazole: pharmacokinetic observations in severely ill patients. Journal of Antimicrobial Chemotherapy. 14(3). 275–283. 12 indexed citations
7.
Rosén, Anders, Bo Ursing, Thor Alm, et al.. (1982). A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology. 83(3). 541–549. 48 indexed citations
8.
Hartley‐Asp, Beryl, Felix Mitelman, & Bo Ursing. (1981). The absence of clastogenic effect during long-term and short-term treatment with metronidazole. Mutation Research/Environmental Mutagenesis and Related Subjects. 85(4). 237–238. 6 indexed citations
9.
Hedström, Sven Åke, Carl‐Erik Nord, & Bo Ursing. (1980). Chronic Meningitis in Patients with Dental Infections. Scandinavian Journal of Infectious Diseases. 12(2). 117–121. 17 indexed citations
10.
Christensson, Bértil, et al.. (1979). Treatment of Anaerobic Infections with Metronidazole. Scandinavian Journal of Infectious Diseases. 11(1). 69–72. 10 indexed citations
11.
Melander, Arne, Gunnar Kahlmeter, C. Kamme, & Bo Ursing. (1977). Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease. European Journal of Clinical Pharmacology. 12(1). 69–72. 28 indexed citations
12.
Ursing, Bo & C. Kamme. (1975). METRONIDAZOLE FOR CROHN'S DISEASE. The Lancet. 305(7910). 775–777. 153 indexed citations
13.
Ursing, Bo, et al.. (1975). Persistent Cerebellar Symptoms after Infection with Mycoplasma Pneumoniae. Scandinavian Journal of Infectious Diseases. 7(2). 157–160. 20 indexed citations
14.
Mårdh, Per‐Anders & Bo Ursing. (1974). The Occurrence of Acute Pancreatitis in Mycoplasma Pneumoniae Infection. Scandinavian Journal of Infectious Diseases. 6(2). 167–171. 38 indexed citations
15.
Kamme, Carl & Bo Ursing. (1974). Serum Levels and Clinical Effect of Flucloxacillin in Patients with Staphylococcal Infections. Scandinavian Journal of Infectious Diseases. 6(3). 273–278. 8 indexed citations
16.
Ursing, Bo. (1973). Acute pancreatitis in coxsackie B infection.. BMJ. 3(5879). 524–525. 59 indexed citations
17.
Mårdh, P.‐A. & Bo Ursing. (1973). Acute pancreatitis in mycoplasma pneumoniae infections.. BMJ. 2(5860). 240.3–241. 11 indexed citations
18.
Stensman, Richard & Bo Ursing. (1971). Epilepsy precipitated by hot water immersion. Neurology. 21(5). 559–559. 48 indexed citations
19.
Dencker, S. J., Bengt Swahn, & Bo Ursing. (1964). Protein Pattern of Cerebrospinal Fluid During the Course of Acute Polyradiculoneuropathy1. Acta Medica Scandinavica. 175(4). 499–506. 7 indexed citations
20.
Ursing, Bo, S. J. Dencker, & Bengt Swahn. (1962). Protein Pattern of Cerebrospinal Fluid in Meningiatis and Meningo‐encephalitis. Acta Medica Scandinavica. 171(6). 715–722. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026